Nifty, Sensex gain amid vaccine hopes; Reliance leads pack
BENGALURU (Reuters) - Indian shares rose on Monday as hopes for imminent coronavirus vaccines helped boost global investor sentiment, while Reliance Industries led gains domestically after winning regulatory approval for a $3.4 billion deal.The NSE Nifty 50 index was up 0.49% at 12,929.15 by 0400 GMT. The S&P BSE Sensex climbed 0.51% to 44,105.39.The first COVID-19 vaccines could be given to U.S. healthcare workers and others recommended by mid-December, a top health official said on Sunday, helping Asian stock markets trade higher on Monday. [MKTS/GLOB]In India, Reliance Industries advanced 3% after the country`s competition watchdog approved its deal to buy Future Group`s retail assets. (Reporting by Sachin Ravikumar in Bengaluru; Editing by Subhranshu Sahu) The story has been taken from a news agency
BENGALURU (Reuters) - Indian shares rose on Monday as hopes for imminent coronavirus vaccines helped boost global investor sentiment, while Reliance Industries led gains domestically after winning regulatory approval for a $3.4 billion deal.
The NSE Nifty 50 index was up 0.49% at 12,929.15 by 0400 GMT. The S&P BSE Sensex climbed 0.51% to 44,105.39.
The first COVID-19 vaccines could be given to U.S. healthcare workers and others recommended by mid-December, a top health official said on Sunday, helping Asian stock markets trade higher on Monday. [MKTS/GLOB]
In India, Reliance Industries advanced 3% after the country`s competition watchdog approved its deal to buy Future Group`s retail assets.
(Reporting by Sachin Ravikumar in Bengaluru; Editing by Subhranshu Sahu)
The story has been taken from a news agency
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.